Procurement: AMRAAMS Against Iran

Archives

August 14, 2009: Two more Middle Eastern nations are buying more American AIM-120C-7 air-to-air missiles. Jordan is buying 85 and Bahrain 25. Both nations fly U.S. made F-16 fighters. The U.S. is supplying Middle Eastern allies with these high end missiles mainly to help contain Iran. The nations receiving the weapons like to talk up the need to halt "Israeli aggression," but the main enemy is, as has it has been for thousands of years, Iran.

AMRAAM entered service in 1992, more than 30 years after the first radar guided air-to-air missile (the AIM-7) entered service. Vietnam provided ample evidence that AIM-7 wasn't really ready for prime time. Too many things could go wrong. Several versions later, the AIM-7 got another combat test during the 1991 Gulf War. While 88 AIM 7s were launched, only 28 percent scored a hit. The AIM 9 Sidewinder did worse, with 97 fired and only 12.6 percent making contact. That said, most of these hits could not have been obtained with cannon, especially when the AIM 7 was used against a target that was trying to get away. AMRAAM was designed to fix all the reliability and ease-of-use problems that cursed the AIM-7. But AMRAAM has only had a few opportunities to be used in combat, although 77 percent of the 13 launched have hit something.

The 340 pound AMRAAM isn't much bigger that the 200 pound, heat seeking, AIM-9 Sidewinder, but has a much longer (70 kilometers versus 18) range. AMRAAMs cost about $1.1 million each.

 

 


Article Archive

Procurement: Current 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 


X

ad
0
20

Help Keep Us Soaring

We need your help! Our subscription base has slowly been dwindling. We need your help in reversing that trend. We would like to add 20 new subscribers this month.

Each month we count on your subscriptions or contributions. You can support us in the following ways:

  1. Make sure you spread the word about us. Two ways to do that are to like us on Facebook and follow us on Twitter.
  2. Subscribe to our daily newsletter. We’ll send the news to your email box, and you don’t have to come to the site unless you want to read columns or see photos.
  3. You can contribute to the health of StrategyPage. A contribution is not a donation that you can deduct at tax time, but a form of crowdfunding. We store none of your information when you contribute..
Subscribe   Contribute   Close